Annual report pursuant to Section 13 and 15(d)

SEGMENT INFORMATION (Tables)

v3.22.1
SEGMENT INFORMATION (Tables)
12 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information
The following table presents information by reportable operating segment for the years ended December 31, 2021 and 2020 (in thousands):
Consumer Products
Segment
Specialty Pharmaceutical Segment Totals
Year ended December 31, 2021:      
Product sales, net $ 20,048  $ —  $ 20,048 
Gross profit $ 8,616  $ —  $ 8,616 
Research and development 492  693  1,185 
Selling, general and administrative 20,783  5,094  25,877 
Operating loss $ (12,659) $ (5,787) $ (18,446)
Year ended December 31, 2020:
Product sales, net $ 24,429  $ —  $ 24,429 
Gross profit $ 11,009  $ —  $ 11,009 
Research and development 678  2,265  2,943 
Selling, general and administrative 30,547  111  30,658 
Operating loss $ (20,216) $ (2,376) $ (22,592)